These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1387846)

  • 1. Two directions of dopamine D1/D2 receptor interaction in studies of behavioural regulation: a finding generic to four new, selective dopamine D1 receptor antagonists.
    Daly SA; Waddington JL
    Eur J Pharmacol; 1992 Mar; 213(2):251-8. PubMed ID: 1387846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for dopamine 'D1-like' receptor subtypes in the behavioural effects of two new selective antagonists, LY 270411 and BW 737C.
    Deveney AM; Waddington JL
    Eur J Pharmacol; 1996 Dec; 317(2-3):175-81. PubMed ID: 8997598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of clozapine on behavioural responses to the selective 'D1-like' dopamine receptor agonist, A 68930, and to the selective 'D2-like' agonist, RU 24213.
    Daly SA; Waddington JL
    Br J Pharmacol; 1994 Nov; 113(3):839-44. PubMed ID: 7858875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.
    Deveney AM; Waddington JL
    Br J Pharmacol; 1995 Oct; 116(3):2120-6. PubMed ID: 8640354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the new atypical antipsychotics olanzapine and ICI 204,636 with clozapine on behavioural responses to the selective "D1-like" dopamine receptor agonist A 68930 and selective "D2-like" agonist RU 24213.
    Deveney AM; Waddington JL
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):40-9. PubMed ID: 8935799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related changes in the regulation of behavior by D-1:D-2 dopamine receptor interactions.
    Murray AM; Waddington JL
    Neurobiol Aging; 1991; 12(5):431-5. PubMed ID: 1837593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioural evidence for "D-1-like" dopamine receptor subtypes in rat brain using the new isochroman agonist A 68930 and isoquinoline antagonist BW 737C.
    Daly SA; Waddington JL
    Psychopharmacology (Berl); 1993; 113(1):45-50. PubMed ID: 7862827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New classes of selective D-1 dopamine receptor antagonist provide further evidence for two directions of D-1:D-2 interaction.
    Daly SA; Waddington JL
    Neurochem Int; 1992 Mar; 20 Suppl():135S-139S. PubMed ID: 1365412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of clozapine with dopamine D1 versus dopamine D2 receptor-mediated function: behavioural indices.
    Murray AM; Waddington JL
    Eur J Pharmacol; 1990 Sep; 186(1):79-86. PubMed ID: 2149339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the selectivities of SCH 23390 with BW737C89 for D1, D2 and 5-HT2 binding sites both in vitro and in vivo.
    Riddall DR
    Eur J Pharmacol; 1992 Jan; 210(3):279-84. PubMed ID: 1351844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural responses to the selective D1-dopamine receptor agonist R-SK&F 38393 and the selective D2-agonist RU 24213 in young compared with aged rats.
    Molloy AG; Waddington JL
    Br J Pharmacol; 1988 Oct; 95(2):335-42. PubMed ID: 2906555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the putative D-1 antagonist SCH 23390 on stereotyped behaviour induced by the D-2 agonist RU24213.
    Pugh MT; O'Boyle KM; Molloy AG; Waddington JL
    Psychopharmacology (Berl); 1985; 87(3):308-12. PubMed ID: 2934758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration.
    Britton DR; Curzon P; Mackenzie RG; Kebabian JW; Williams JE; Kerkman D
    Pharmacol Biochem Behav; 1991 Aug; 39(4):911-5. PubMed ID: 1684870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive and negative interactions in the behavioural expression of D1 and D2 receptor stimulation in a model of Parkinsonism: role of priming.
    Morelli M; Fenu S; Cozzolino A; Di Chiara G
    Neuroscience; 1991; 42(1):41-8. PubMed ID: 1830642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390.
    Molloy AG; Waddington JL
    Psychopharmacology (Berl); 1984; 82(4):409-10. PubMed ID: 6427836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ; Albers LJ; Le H; Creese I
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic D1-receptor blockade: effects on D2-receptor agonist-induced yawning in rats.
    Hietala J; Lappalainen J; Syvälahti E
    J Pharm Pharmacol; 1991 Apr; 43(4):278-9. PubMed ID: 1676742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other "D-2-like" agonists.
    Daly SA; Waddington JL
    Neuropharmacology; 1993 May; 32(5):509-10. PubMed ID: 8321432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.
    Braun AR; Laruelle M; Mouradian MM
    J Neural Transm (Vienna); 1997; 104(4-5):341-62. PubMed ID: 9295170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.